{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:16:31Z","timestamp":1793999791485,"version":"4.8.0"},"reference-count":167,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["AG063839"],"award-info":[{"award-number":["AG063839"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["HL166538"],"award-info":[{"award-number":["HL166538"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["HL151627"],"award-info":[{"award-number":["HL151627"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["HL157073"],"award-info":[{"award-number":["HL157073"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["HL170000"],"award-info":[{"award-number":["HL170000"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013142","name":"Key Research and Development Project of Hainan Province","doi-asserted-by":"publisher","award":["2024YFA1802300"],"award-info":[{"award-number":["2024YFA1802300"]}],"id":[{"id":"10.13039\/501100013142","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82500367"],"award-info":[{"award-number":["82500367"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20270"],"award-info":[{"award-number":["U22A20270"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.pharmthera.2026.109026","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T16:06:08Z","timestamp":1773504368000},"page":"109026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Innate immune responses following myocardial ischemia and reperfusion: Evidence, mechanisms, and translational challenges"],"prefix":"10.1016","volume":"282","author":[{"given":"Shuya","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengju","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Ping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.pharmthera.2026.109026_bb0005","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/CIRCULATIONAHA.124.069396","article-title":"Results of international, double-blind, randomized, placebo-controlled, phase IIa study of Interleukin-1 blockade with RPH-104 (Goflikicept) in patients with ST-segment-elevation myocardial infarction (STEMI)","volume":"150","author":"Abbate","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0010","doi-asserted-by":"crossref","unstructured":"Ao-Di, F., Han-Qing, L., Xi-Zheng, W., Ke, Y., Hong-Xin, G., Hai-Xia, Z., Guan-Wei, F., & Li-Lan null. (2024). Advances in macrophage metabolic reprogramming in myocardial ischemia-reperfusion. Cellular Signalling, 123, 111370. doi:https:\/\/doi.org\/10.1016\/j.cellsig.2024.111370.","DOI":"10.1016\/j.cellsig.2024.111370"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109026_bb0015","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrcardio.2011.38","article-title":"Innate immune signaling in cardiac ischemia","volume":"8","author":"Arslan","year":"2011","journal-title":"Nature Reviews Cardiology"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.109026_bb0020","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/CIRCULATIONAHA.114.010482","article-title":"Targeting pathogenic post-ischemic self-recognition by natural IgM to protect against post-transplant cardiac reperfusion injury","volume":"131","author":"Atkinson","year":"2015","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.pharmthera.2026.109026_bb0025","doi-asserted-by":"crossref","first-page":"7165","DOI":"10.3390\/ijms21197165","article-title":"Innate immunity effector cells as inflammatory drivers of cardiac fibrosis","volume":"21","author":"Baci","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109026_bb0030","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s11886-023-01897-4","article-title":"The role of innate immune cells in cardiac injury and repair: A metabolic perspective","volume":"25","author":"Banerjee","year":"2023","journal-title":"Current Cardiology Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109026_bb0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00395-023-00999-y","article-title":"Matrix metalloproteinase-2 proteolyzes mitofusin-2 and impairs mitochondrial function during myocardial ischemia-reperfusion injury","volume":"118","author":"Bassiouni","year":"2023","journal-title":"Basic Research in Cardiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109026_bb0040","article-title":"Single-cell dissection of the immune response after acute myocardial infarction","volume":"17","author":"van Blokland","year":"2024","journal-title":"Circulation: Genomic and Precision Medicine"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109026_bb0045","doi-asserted-by":"crossref","first-page":"7014","DOI":"10.4049\/jimmunol.1001888","article-title":"Induction of cardiac angiogenesis requires killer cell lectin-like receptor 1 and \u03b14\u03b27 integrin expression by NK cells","volume":"185","author":"Bouchentouf","year":"2010","journal-title":"Journal of Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109026_bb0050","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.cyto.2011.09.023","article-title":"Interleukin-2 enhances angiogenesis and preserves cardiac function following myocardial infarction","volume":"56","author":"Bouchentouf","year":"2011","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109026_bib836","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1172\/JCI112160","article-title":"Myocardial reperfusion: A double-edged sword?","volume":"76","author":"Braunwald","year":"1985","journal-title":"The Journal of Clinical Investigation"},{"issue":"15","key":"10.1016\/j.pharmthera.2026.109026_bb0055","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","article-title":"Randomized trial of Interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction","volume":"77","author":"Broch","year":"2021","journal-title":"Journal of the American College of Cardiology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109026_bb0060","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/CIRCULATIONAHA.105.575993","article-title":"Receptor for advanced-glycation end products: Key modulator of myocardial ischemic injury","volume":"113","author":"Bucciarelli","year":"2006","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.pharmthera.2026.109026_bb0065","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1161\/CIRCULATIONAHA.118.035736","article-title":"Macrophages in cardiovascular homeostasis and disease","volume":"138","author":"Cao","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109026_bb0070","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201900424","article-title":"aYAP modRNA reduces cardiac inflammation and hypertrophy in a murine ischemia-reperfusion model","volume":"3","author":"Chen","year":"2020","journal-title":"Life Science Alliance"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109026_bb0075","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni.3558","article-title":"Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing","volume":"17","author":"Chen","year":"2016","journal-title":"Nature Immunology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109026_bb0080","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/SHK.0000000000001532","article-title":"MiR-433 regulates myocardial ischemia reperfusion injury by targeting NDRG4 via the PI3K\/Akt pathway","volume":"54","author":"Cheng","year":"2020","journal-title":"Shock"},{"issue":"18","key":"10.1016\/j.pharmthera.2026.109026_bb0085","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1016\/j.scib.2024.05.025","article-title":"Targeting neutrophil subsets is a novel approach for myocardial ischemia-reperfusion injury","volume":"69","author":"Chereshnev","year":"2024","journal-title":"Science Bulletin"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1532325","article-title":"The N-6 methyladenosine dynamics in STEMI and the effect of IL-6 inhibition\u2014A hypothesis generating sub-study of the ASSAIL-MI trial","volume":"16","author":"Dahl","year":"2025","journal-title":"Frontiers in Immunology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109026_bb0095","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1055\/s-0040-1708035","article-title":"Thrombo-inflammation in cardiovascular disease: An expert consensus document from the third Maastricht consensus conference on thrombosis","volume":"120","author":"d\u2019Alessandro","year":"2020","journal-title":"Thrombosis and Haemostasis"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109026_bb0100","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1093\/cvr\/cvab200","article-title":"Progress in cardiac research: From rebooting cardiac regeneration to a complete cell atlas of the heart","volume":"117","author":"Davidson","year":"2021","journal-title":"Cardiovascular Research"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109026_bb0105","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1161\/CIRCRESAHA.117.311327","article-title":"MerTK cleavage on resident cardiac macrophages compromises repair after myocardial ischemia reperfusion injury","volume":"121","author":"DeBerge","year":"2017","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0110","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3389\/fimmu.2020.00802","article-title":"Unique phenotypes of heart resident type 2 innate lymphoid cells","volume":"11","author":"Deng","year":"2020","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0115","article-title":"Ozone pretreatment alleviates ischemiareperfusion injury-induced myocardial ferroptosis by activating the Nrf2\/Slc7a11\/Gpx4 axis","volume":"165","author":"Ding","year":"2023","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109026_bb0120","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.scib.2024.02.003","article-title":"Single-cell profile reveals the landscape of cardiac immunity and identifies a cardio-protective Ym-1hi neutrophil in myocardial ischemia\u2013reperfusion injury","volume":"69","author":"Dong","year":"2024","journal-title":"Science Bulletin"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109026_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1741","article-title":"Inhibiting the cGAS-STING pathway in myeloid cells effectively improves myocardial healing related to TET2 deficiency-induced DNA damage response","volume":"14","author":"Dou","year":"2024","journal-title":"Clinical and Translational Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109026_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-025-02372-5","article-title":"Different types of cell death and their interactions in myocardial ischemia\u2013reperfusion injury","volume":"11","author":"Du","year":"2025","journal-title":"Cell Death Discovery"},{"issue":"21","key":"10.1016\/j.pharmthera.2026.109026_bb0135","article-title":"Flavonifractor plautii or its metabolite desaminotyrosine as prophylactic agents for alleviating myocardial ischemia\/reperfusion injury","volume":"12","author":"Du","year":"2025","journal-title":"Advanced Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109026_bb0140","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1038\/s41598-024-54086-w","article-title":"Differential gene expression patterns in ST-elevation myocardial infarction and non-ST-elevation myocardial infarction","volume":"14","author":"Elahimanesh","year":"2024","journal-title":"Scientific Reports"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109026_bb0145","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/CIRCRESAHA.122.322227","article-title":"ZBP1 protects against mtDNA-induced myocardial inflammation in failing hearts","volume":"132","author":"Enzan","year":"2023","journal-title":"Circulation Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109026_bb0150","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nri3800","article-title":"Role of innate and adaptive immune mechanisms in cardiac injury and repair","volume":"15","author":"Epelman","year":"2015","journal-title":"Nature Reviews Immunology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109026_bb0155","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/CIRCULATIONAHA.118.036044","article-title":"Dectin-1 contributes to myocardial ischemia\/reperfusion injury by regulating macrophage polarization and neutrophil infiltration","volume":"139","author":"Fan","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrep.2023.101434","article-title":"The role of complement C3 in the outcome of regional myocardial infarction","volume":"33","author":"Fang","year":"2023","journal-title":"Biochemistry and Biophysics Reports"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0165","article-title":"Identification of genes linking natural killer cells to apoptosis in acute myocardial infarction and ischemic stroke","volume":"13","author":"Feng","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"44","key":"10.1016\/j.pharmthera.2026.109026_bb0170","doi-asserted-by":"crossref","first-page":"26688","DOI":"10.1074\/jbc.M115.661835","article-title":"Cardiac RNA induces inflammatory responses in cardiomyocytes and immune cells via toll-like receptor 7 signaling","volume":"290","author":"Feng","year":"2015","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109026_bb0175","doi-asserted-by":"crossref","first-page":"H1311","DOI":"10.1152\/ajpheart.00119.2008","article-title":"Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice","volume":"295","author":"Feng","year":"2008","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109026_bb0180","doi-asserted-by":"crossref","first-page":"C760","DOI":"10.1152\/ajpcell.00155.2010","article-title":"Bone marrow MyD88 signaling modulates neutrophil function and ischemic myocardial injury","volume":"299","author":"Feng","year":"2010","journal-title":"American Journal of Physiology-Cell Physiology"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0185","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.peptides.2015.06.013","article-title":"Chromofungin, CgA47-66-derived peptide, produces basal cardiac effects and postconditioning cardioprotective action during ischemia\/reperfusion injury","volume":"71","author":"Filice","year":"2015","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0190","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1975167","article-title":"Apoptosis and mobilization of lymphocytes to cardiac tissue is associated with myocardial infarction in a reperfused porcine model and infarct size in post-PCI patients","volume":"2018","author":"Forteza","year":"2018","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109026_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12111944","article-title":"Inflammation in myocardial ischemia\/reperfusion injury: Underlying mechanisms and therapeutic potential","volume":"12","author":"Francisco","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0200","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.2147\/IJN.S500146","article-title":"Nanomaterials: Promising tools for the diagnosis and treatment of myocardial infarction","volume":"20","author":"Ge","year":"2025","journal-title":"International Journal of Nanomedicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109026_bb0205","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.freeradbiomed.2010.01.006","article-title":"Linking oxidative stress to inflammation: Toll-like receptors","volume":"48","author":"Gill","year":"2010","journal-title":"Free Radical Biology & Medicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109026_bb0210","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140685","article-title":"Macrophage-produced VEGFC is induced by efferocytosis to ameliorate cardiac injury and inflammation","volume":"132","author":"Glinton","year":"2022","journal-title":"The Journal of Clinical Investigation"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109026_bb0215","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/1440-1681.12465","article-title":"Immunomodulation by splenectomy or by FTY720 protects the heart against ischemia reperfusion injury","volume":"42","author":"Goltz","year":"2015","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109026_bb0220","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1161\/CIRCULATIONAHA.111.018176","article-title":"Inflammasome activation in reperfusion injury: Friendly fire on myocardial infarction?","volume":"123","author":"Grundmann","year":"2011","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109026_bb0225","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/cvr\/cvq141","article-title":"Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction","volume":"87","author":"Haas","year":"2010","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0230","article-title":"CD47 blockade enhances phagocytosis of cardiac cell debris by neutrophils","volume":"48","author":"Haj-Yehia","year":"2023","journal-title":"International Journal of Cardiology Heart & Vasculature"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109026_bb0235","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13020-024-00925-x","article-title":"Oleuropein alleviates myocardial ischemia\u2013reperfusion injury by suppressing oxidative stress and excessive autophagy via TLR4\/MAPK signaling pathway","volume":"19","author":"He","year":"2024","journal-title":"Chinese Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109026_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/etm.2022.11357","article-title":"Myocardial ischemia\/reperfusion injury: Mechanisms of injury and implications for management (review)","volume":"23","author":"He","year":"2022","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109026_bb0245","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.medj.2023.12.007","article-title":"Myocardial ischemia\/reperfusion: Translational pathophysiology of ischemic heart disease","volume":"5","author":"Heusch","year":"2024","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109026_bb0250","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/cvr\/cvv224","article-title":"BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia\u2013reperfusion injury","volume":"108","author":"de Hoog","year":"2015","journal-title":"Cardiovascular Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109026_bb0255","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00395-015-0513-6","article-title":"Elevated mean neutrophil volume represents altered neutrophil composition and reflects damage after myocardial infarction","volume":"110","author":"van Hout","year":"2015","journal-title":"Basic Research in Cardiology"},{"issue":"21","key":"10.1016\/j.pharmthera.2026.109026_bb0260","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202415205","article-title":"MMP9High neutrophils are critical mediators of neutrophil extracellular traps formation and myocardial ischemia\/reperfusion injury","volume":"12","author":"Hu","year":"2025","journal-title":"Advanced Science"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109026_bb0265","doi-asserted-by":"crossref","first-page":"7317","DOI":"10.4049\/jimmunol.178.11.7317","article-title":"Protection against myocardial ischemia\/reperfusion injury in TLR4-deficient mice is mediated through a phosphoinositide 3-kinase-dependent mechanism","volume":"178","author":"Hua","year":"2007","journal-title":"Journal of Immunology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109026_bb0270","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.167201","article-title":"B cell subsets contribute to myocardial protection by inducing neutrophil apoptosis after ischemia and reperfusion","volume":"9","author":"Huang","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0275","series-title":"The protective role of ILC3s glycolysis in myocardial ischemia-reperfusion injury: Unveiling metabolic and immune regulatory mechanisms","author":"Huijun","year":"2025"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104013","article-title":"Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial","volume":"80","author":"Huse","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105960","article-title":"The effects of interleukin-6-receptor inhibition on monocytes in STEMI: A substudy of the ASSAIL-MI trial","volume":"121","author":"Huse","year":"2025","journal-title":"EBioMedicine"},{"issue":"7213","key":"10.1016\/j.pharmthera.2026.109026_bb0290","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature07317","article-title":"STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling","volume":"455","author":"Ishikawa","year":"2008","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109026_bb0295","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jacbts.2020.03.015","article-title":"Innate immune receptors, key actors in cardiovascular diseases","volume":"5","author":"Ja\u00e9n","year":"2020","journal-title":"JACC Basic to Translational Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109026_bb0300","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1749-6632.1969.tb16718.x","article-title":"Ischemic injury of myocardium","volume":"156","author":"Jennings","year":"1969","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0305","article-title":"Single-cell landscape dissecting the transcription and heterogeneity of innate lymphoid cells in ischemic heart","volume":"14","author":"Jiang","year":"2023","journal-title":"Frontiers in Immunology"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109026_bb0310","doi-asserted-by":"crossref","first-page":"419","DOI":"10.31083\/j.rcm2511419","article-title":"The role of cardiac macrophages in inflammation and fibrosis after myocardial ischemia-reperfusion","volume":"25","author":"Jin","year":"2024","journal-title":"Reviews in Cardiovascular Medicine"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0315","doi-asserted-by":"crossref","unstructured":"Jolly, S. S., d'Entremont, M.-A., Lee, S. F., Mian, R., Tyrwhitt, J., Kedev, S., Montalescot, G., Cornel, J. H., Stankovi\u0107, G., Moreno, R., Storey, R. F., Henry, T. D., Mehta, S. R., Bossard, M., Kala, P., Layland, J., Zafirovska, B., Devereaux, P. J., Eikelboom, J., \u2026 CLEAR Investigators. (2025). Colchicine in acute myocardial infarction. The New England Journal of Medicine, 392(7), 633\u2013642. doi:https:\/\/doi.org\/10.1056\/NEJMoa2405922.","DOI":"10.1056\/NEJMoa2405922"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109026_bb0320","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.jnutbio.2011.10.004","article-title":"Curcumin reduces the cardiac ischemia-reperfusion injury: Involvement of the toll-like receptor 2 in cardiomyocytes","volume":"23","author":"Kim","year":"2012","journal-title":"The Journal of Nutritional Biochemistry"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109026_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101193","article-title":"Neutrophil extracellular traps in ST-segment elevation myocardial infarction: Reduced by tocilizumab and associated with infarct size","volume":"3","author":"Kindberg","year":"2024","journal-title":"JACC. Advances"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109026_bb0330","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/nm.4428","article-title":"IRF3 and type I interferons fuel a fatal response to myocardial infarction","volume":"23","author":"King","year":"2017","journal-title":"Nature Medicine"},{"issue":"Supplement_1","key":"10.1016\/j.pharmthera.2026.109026_bb0335","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae666.1502","article-title":"Combined activation of complement and coagulation is associated with myocardial injury in ST-elevation myocardial infarction","volume":"45","author":"Kluge","year":"2024","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0340","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fphys.2014.00295","article-title":"Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction","volume":"5","author":"Knorr","year":"2014","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0345","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.664457","article-title":"Cells of the immune system in cardiac remodeling: Main players in resolution of inflammation and repair after myocardial infarction","volume":"12","author":"Kologrivova","year":"2021","journal-title":"Frontiers in Immunology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109026_bb0350","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/ATVBAHA.113.301437","article-title":"Angiotensin II\u2013induced vascular dysfunction depends on interferon-\u03b3\u2013driven immune cell recruitment and mutual activation of monocytes and NK-cells","volume":"33","author":"Kossmann","year":"2013","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"15","key":"10.1016\/j.pharmthera.2026.109026_bb0355","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.020754","article-title":"Plasmacytoid dendritic cells mediate myocardial ischemia\/reperfusion injury by secreting type I interferons","volume":"10","author":"Lai","year":"2021","journal-title":"Journal of the American Heart Association"},{"issue":"Supplement_1","key":"10.1016\/j.pharmthera.2026.109026_bb0360","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae666.1518","article-title":"TLR7 deficiency alleviated myocardial ischemia reperfusion injury via regulating macrophage-neutrophil interaction","volume":"45","author":"Lai","year":"2024","journal-title":"European Heart Journal"},{"issue":"21","key":"10.1016\/j.pharmthera.2026.109026_bb0365","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.jacc.2024.03.408","article-title":"Clinical outcomes associated with various microvascular injury patterns identified by CMR after STEMI","volume":"83","author":"Lechner","year":"2024","journal-title":"Journal of the American College of Cardiology"},{"issue":"36","key":"10.1016\/j.pharmthera.2026.109026_bb0370","doi-asserted-by":"crossref","first-page":"31308","DOI":"10.1074\/jbc.M111.246124","article-title":"Myocardial ischemia activates an injurious innate immune signaling via cardiac heat shock protein 60 and toll-like receptor 4","volume":"286","author":"Li","year":"2011","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0375","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.bcp.2019.03.022","article-title":"Modulation of innate immunity by cyclosporine A","volume":"163","author":"Liddicoat","year":"2019","journal-title":"Biochemical Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109026_bb0380","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.035383","article-title":"Changes in blood eosinophil counts predict the death of patients with myocardial infarction after hospital discharge","volume":"14","author":"Lin","year":"2025","journal-title":"Journal of the American Heart Association"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109026_bb0385","doi-asserted-by":"crossref","first-page":"6396","DOI":"10.1038\/s41467-020-19297-5","article-title":"Eosinophils improve cardiac function after myocardial infarction","volume":"11","author":"Liu","year":"2020","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109026_bb0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41421-023-00622-3","article-title":"The E3 ubiquitin ligase MARCH2 protects against myocardial ischemia-reperfusion injury through inhibiting pyroptosis via negative regulation of PGAM5\/MAVS\/NLRP3 axis","volume":"10","author":"Liu","year":"2024","journal-title":"Cell Discovery"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109026_bb0395","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/cvr\/cvac144","article-title":"Group 2 innate lymphoid cells protect mouse heart from myocardial infarction injury via interleukin 5, eosinophils, and dendritic cells","volume":"119","author":"Liu","year":"2023","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0400","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/s41467-025-57048-6","article-title":"Identification of splenic IRF7 as a nanotherapy target for tele-conditioning myocardial reperfusion injury","volume":"16","author":"Long","year":"2025","journal-title":"Nature Communications"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109026_bb0405","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1594","article-title":"High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal","volume":"5","author":"Lotze","year":"2005","journal-title":"Nature Reviews. Immunology"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109026_bb0410","first-page":"1210","article-title":"Absence of NLRP3 Inflammasome in hematopoietic cells reduces adverse remodeling after experimental myocardial infarction","volume":"5","author":"Louwe","year":"2020","journal-title":"JACC: Basic to translational Science"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109026_bb0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068154","article-title":"N-terminal truncated intracellular matrix metalloproteinase-2 induces cardiomyocyte hypertrophy, inflammation and systolic heart failure","volume":"8","author":"Lovett","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109026_bb0420","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbadis.2013.10.006","article-title":"Toll-like receptor 3 plays a role in myocardial infarction and ischemia\/reperfusion injury","volume":"1842","author":"Lu","year":"2014","journal-title":"Biochimica et Biophysica Acta"},{"issue":"41","key":"10.1016\/j.pharmthera.2026.109026_bb0425","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202403542","article-title":"Engineered macrophage membrane-coated S100A9-siRNA for ameliorating myocardial ischemia-reperfusion injury","volume":"11","author":"Lu","year":"2024","journal-title":"Advanced Science"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115458","article-title":"Stimulator of interferon genes (STING): Key therapeutic targets in ischemia\/reperfusion injury","volume":"167","author":"Lv","year":"2023","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"32","key":"10.1016\/j.pharmthera.2026.109026_bb0435","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1093\/eurheartj\/ehz461","article-title":"Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction","volume":"40","author":"Marinkovi\u0107","year":"2019","journal-title":"European Heart Journal"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109026_bb0440","article-title":"Rapid fall in circulating non-classical monocytes in ST elevation myocardial infarction patients correlates with cardiac injury","volume":"35","author":"Marsh","year":"2021","journal-title":"FASEB Journal\u202f: Official Publication of the Federation of American Societies for Experimental Biology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109026_bb0445","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Molecular Cell"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109026_bb0450","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5271251","article-title":"Pharmacological inhibition of NLRP3 Inflammasome attenuates myocardial ischemia\/reperfusion injury by activation of RISK and mitochondrial pathways","volume":"2016","author":"Mastrocola","year":"2016","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"5566","key":"10.1016\/j.pharmthera.2026.109026_bb0455","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1071059","article-title":"The danger model: A renewed sense of self","volume":"296","author":"Matzinger","year":"2002","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109026_bb0460","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/FJC.0000000000000452","article-title":"Reduction of myocardial ischemia-reperfusion injury by inhibiting Interleukin-1 alpha","volume":"69","author":"Mauro","year":"2017","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109026_bb0465","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-8674(00)80412-2","article-title":"Innate immunity: The virtues of a nonclonal system of recognition","volume":"91","author":"Medzhitov","year":"1997","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109026_bb0470","doi-asserted-by":"crossref","first-page":"C797","DOI":"10.1152\/ajpcell.00330.2020","article-title":"Monocyte recruitment and fate specification after myocardial infarction","volume":"319","author":"Mentkowski","year":"2020","journal-title":"American Journal of Physiology - Cell Physiology"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109026_bb0475","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/CIRCULATIONAHA.121.056177","article-title":"Effect of colchicine on myocardial injury in acute myocardial infarction","volume":"144","author":"Mewton","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0480","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1097295","article-title":"Immune cells drive new immunomodulatory therapies for myocardial infarction: From basic to clinical translation","volume":"14","author":"Nian","year":"2023","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109026_bb0485","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-04990-6","article-title":"Single-cell RNA sequencing reveals the potential role of Postn(+) fibroblasts in promoting the progression of myocardial fibrosis after myocardial infarction","volume":"15","author":"Nie","year":"2025","journal-title":"Scientific Reports"},{"issue":"4, part 2","key":"10.1016\/j.pharmthera.2026.109026_bb0490","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.lpm.2013.01.004","article-title":"L2. Neutrophil transmigration in vivo: Mechanisms, dynamics and contribution to dissemination of systemic inflammation","volume":"42","author":"Nourshargh","year":"2013","journal-title":"Presse M\u00e9dicale"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109026_bb0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104407","article-title":"Toll-like receptor 9-activation during onset of myocardial ischemia does not influence infarct extension","volume":"9","author":"Ohm","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0500","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clim.2016.11.010","article-title":"Natural killer cells in inflammatory heart disease","volume":"175","author":"Ong","year":"2017","journal-title":"Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0505","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1287465","article-title":"Revisiting regulatory T cells as modulators of innate immune response and inflammatory diseases","volume":"14","author":"Ou","year":"2023","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113428","article-title":"Interleukin-38 ameliorates myocardial ischemia-reperfusion injury via inhibition of NLRP3 inflammasome activation in fibroblasts through the IL-1R8\/SYK axis","volume":"143","author":"Pan","year":"2024","journal-title":"International Immunopharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109026_bb0515","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1042\/CS20140444","article-title":"Toll-like receptor 5 deficiency exacerbates cardiac injury and inflammation induced by myocardial ischaemia-reperfusion in the mouse","volume":"129","author":"Parapanov","year":"2015","journal-title":"Clinical Science"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109026_bb0520","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/cvr\/cvz336","article-title":"Cardiac monocytes and macrophages after myocardial infarction","volume":"116","author":"Peet","year":"2020","journal-title":"Cardiovascular Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109026_bb0525","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/s41591-024-02953-4","article-title":"Multiomic analyses uncover immunological signatures in acute and chronic coronary syndromes","volume":"30","author":"Pekayvaz","year":"2024","journal-title":"Nature Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109026_bb0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199711","article-title":"Caspase recruitment domain-containing protein 9 (CARD9) knockout reduces regional ischemia\/reperfusion injury through an attenuated inflammatory response","volume":"13","author":"Qin","year":"2018","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109026_bb0535","doi-asserted-by":"crossref","DOI":"10.3390\/biom10081167","article-title":"Targeting TLR4 with ApTOLL improves heart function in response to coronary ischemia reperfusion in pigs undergoing acute myocardial infarction","volume":"10","author":"Ramirez-Carracedo","year":"2020","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109026_bb0540","first-page":"633","article-title":"The \u201cwavefront phenomenon\u201d of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow","volume":"40","author":"Reimer","year":"1979","journal-title":"Laboratory Investigation; a Journal of Technical Methods and Pathology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109026_bb0545","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbadis.2012.10.012","article-title":"SR-A deficiency reduces myocardial ischemia\/reperfusion injury; involvement of increased microRNA-125b expression in macrophages","volume":"1832","author":"Ren","year":"2013","journal-title":"Biochimica et Biophysica Acta"},{"issue":"10289","key":"10.1016\/j.pharmthera.2026.109026_bb0550","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): A double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109026_bb0555","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-dose methotrexate for the prevention of atherosclerotic events","volume":"380","author":"Ridker","year":"2019","journal-title":"The New England Journal of Medicine"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109026_bb0560","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206344","article-title":"Characterization and implications of the dynamics of eosinophils in blood and in the infarcted myocardium after coronary reperfusion","volume":"13","author":"Rios-Navarro","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0565","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-immunol-030409-101311","article-title":"The sterile inflammatory response","volume":"28","author":"Rock","year":"2010","journal-title":"Annual Review of Immunology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109026_bb0570","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/s41401-018-0197-1","article-title":"Temporal dynamics of immune response following prolonged myocardial ischemia\/reperfusion with and without cyclosporine A","volume":"40","author":"Rusinkevich","year":"2019","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12950-023-00327-0","article-title":"Progranulin (PGRN) as a regulator of inflammation and a critical factor in the immunopathogenesis of cardiovascular diseases","volume":"20","author":"Saeedi-Boroujeni","year":"2023","journal-title":"Journal of Inflammation (London, England)"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109026_bb0580","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1161\/CIRCRESAHA.116.309001","article-title":"Proliferation and recruitment contribute to myocardial macrophage expansion in chronic heart failure","volume":"119","author":"Sager","year":"2016","journal-title":"Circulation Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109026_bb0585","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.bbrc.2015.12.051","article-title":"NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective","volume":"469","author":"Sandanger.","year":"2016","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109026_bb0595","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1182\/blood-2013-07-514992","article-title":"VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia\/reperfusion injury in mice","volume":"123","author":"Savchenko","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0600","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.yjmcc.2023.02.001","article-title":"Hydrogel delivery of purinergic enzymes improves cardiac ischemia\/reperfusion injury","volume":"176","author":"Sayegh","year":"2023","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109026_bb0605","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.jacbts.2022.04.009","article-title":"Therapeutics that promote sympathetic Reinnervation modulate the inflammatory response after myocardial infarction","volume":"7","author":"Sepe","year":"2022","journal-title":"JACC Basic to Translational Science"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109026_bb0610","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.7150\/thno.91180","article-title":"Single-cell RNA sequencing reveals S100a9hi macrophages promote the transition from acute inflammation to fibrotic remodeling after myocardial ischemia\u2013reperfusion","volume":"14","author":"Shen","year":"2024","journal-title":"Theranostics"},{"issue":"Pt B","key":"10.1016\/j.pharmthera.2026.109026_bb0615","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.yjmcc.2015.10.013","article-title":"Cardio-protective effects of pentraxin 3 produced from bone marrow-derived cells against ischemia\/reperfusion injury","volume":"89","author":"Shimizu","year":"2015","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109026_bb0620","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006949","article-title":"Adenosine production by biomaterial-supported mesenchymal stromal cells reduces the innate inflammatory response in myocardial ischemia\/reperfusion injury","volume":"7","author":"Shin","year":"2018","journal-title":"Journal of the American Heart Association"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109026_bb0625","article-title":"HuR inhibition reduces post-ischemic cardiac remodeling by dampening myocyte-dependent inflammatory gene expression and the innate immune response","volume":"39","author":"Slone","year":"2025","journal-title":"FASEB Journal\u202f: Official Publication of the Federation of American Societies for Experimental Biology"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110008","article-title":"Beclin-1 overexpression regulates NLRP3 activation by promoting TNFAIP3 in microvascular injury following myocardial reperfusion","volume":"84","author":"Sun","year":"2021","journal-title":"Cellular Signalling"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109026_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24029","article-title":"Advances in crosstalk among innate immune pathways activated by mitochondrial DNA","volume":"10","author":"Tao","year":"2024","journal-title":"Heliyon"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109026_bb0640","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.3390\/biomedicines12081728","article-title":"The cGAS-STING pathway: A new therapeutic target for ischemia-reperfusion injury in acute myocardial infarction?","volume":"12","author":"Tian","year":"2024","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109026_bb0645","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.jtcvs.2018.09.043","article-title":"The myocardial infarct-exacerbating effect of cell-free DNA is mediated by the high-mobility group box 1-receptor for advanced glycation end products-toll-like receptor 9 pathway","volume":"157","author":"Tian","year":"2019","journal-title":"The Journal of Thoracic and Cardiovascular Surgery"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109026_bb0650","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/ehjacc\/zuab110","article-title":"Association of plasma interleukin-6 with infarct size, reperfusion injury, and adverse remodelling after ST-elevation myocardial infarction","volume":"11","author":"Tiller","year":"2022","journal-title":"European Heart Journal Acute Cardiovascular Care"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109026_bb0655","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/CIRCRESAHA.107.158220","article-title":"Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction","volume":"102","author":"Timmers","year":"2008","journal-title":"Circulation Research"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109026_bb0660","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jacbts.2020.05.005","article-title":"Eosinophil deficiency promotes aberrant repair and adverse remodeling following acute myocardial infarction","volume":"5","author":"Toor","year":"2020","journal-title":"fChemosphfJACC Basic to Translational Science"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0665","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.870811","article-title":"Intracellular complement component 3 attenuated ischemia-reperfusion injury in the isolated buffer-perfused mouse heart and is associated with improved metabolic homeostasis","volume":"13","author":"Torp","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109026_bb0670","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jacbts.2021.07.001","article-title":"Clec4e-receptor signaling in myocardial repair after ischemia-reperfusion injury","volume":"6","author":"Veltman","year":"2021","journal-title":"JACC Basic to Translational Science"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109026_bb0675","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00395-012-0250-z","article-title":"S100A8\/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-\u03baB signaling","volume":"107","author":"Volz","year":"2012","journal-title":"Basic Research in Cardiology"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109026_bb0680","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/CIRCRESAHA.124.325212","article-title":"CAR-macrophage therapy alleviates myocardial ischemia-reperfusion injury","volume":"135","author":"Wang","year":"2024","journal-title":"Circulation Research"},{"issue":"16","key":"10.1016\/j.pharmthera.2026.109026_bb0685","doi-asserted-by":"crossref","first-page":"6210","DOI":"10.7150\/ijbs.75434","article-title":"Lactylation of PKM2 suppresses inflammatory metabolic adaptation in pro-inflammatory macrophages","volume":"18","author":"Wang","year":"2022","journal-title":"International Journal of Biological Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109026_bb0690","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41392-025-02216-9","article-title":"STING aggravates ferroptosis-dependent myocardial ischemia-reperfusion injury by targeting GPX4 for autophagic degradation","volume":"10","author":"Wang","year":"2025","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0695","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.89377.4","article-title":"Resident and recruited macrophages differentially contribute to cardiac healing after myocardial ischemia","volume":"12","author":"Weinberger","year":"2024","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109026_bb0700","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.70133","article-title":"TLR4 inhibition attenuated LPS-induced Proinflammatory signaling and cytokine release in mouse hearts and cardiomyocytes","volume":"13","author":"Wiger","year":"2025","journal-title":"Immunity, Inflammation and Disease"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109026_bb0705","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/cei.12284","article-title":"Interleukin-37 ameliorates myocardial ischaemia\/reperfusion injury in mice","volume":"176","author":"Wu","year":"2014","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0710","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1081719","article-title":"Characterization of early myocardial inflammation in ischemia-reperfusion injury","volume":"13","author":"Wu","year":"2023","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109026_bb0715","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1186\/s12967-025-06726-6","article-title":"Temporal dynamics of the multi-omic response reveals the modulation of macrophage subsets post-myocardial infarction","volume":"23","author":"Wu","year":"2025","journal-title":"Journal of Translational Medicine"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109026_bb0720","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s44161-025-00717-y","article-title":"Spatial multiomics of acute myocardial infarction reveals immune cell infiltration through the endocardium","volume":"4","author":"W\u00fcnnemann","year":"2025","journal-title":"Nature Cardiovascular Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109026_bb0730","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00395-023-01014-0","article-title":"Splenic monocytes mediate inflammatory response and exacerbate myocardial ischemia\/reperfusion injury in a mitochondrial cell-free DNA-TLR9-NLRP3-dependent fashion","volume":"118","author":"Xie","year":"2023","journal-title":"Basic Research in Cardiology"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0735","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.yrtph.2017.07.028","article-title":"Exogenous administration of mitochondrial DNA promotes ischemia reperfusion injury via TLR9-p38 MAPK pathway","volume":"89","author":"Xie","year":"2017","journal-title":"Regulatory Toxicology and Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109026_bb0740","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.7150\/thno.53326","article-title":"The pivotal roles of exosomes derived from endogenous immune cells and exogenous stem cells in myocardial repair after acute myocardial infarction","volume":"11","author":"Xiong","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0745","doi-asserted-by":"crossref","first-page":"5971","DOI":"10.2147\/JIR.S436560","article-title":"Macrophage heterogeneity and its impact on myocardial ischemia-reperfusion injury: An integrative review","volume":"16","author":"Xu","year":"2023","journal-title":"Journal of Inflammation Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109026_bb0750","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1111\/jcmm.14192","article-title":"The role of dendritic cells regulated by HMGB1\/TLR4 signalling pathway in myocardial ischaemia reperfusion injury","volume":"23","author":"Xue","year":"2019","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0755","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yjmcc.2013.04.023","article-title":"Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction","volume":"62","author":"Yan","year":"2013","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109026_bb0760","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1016\/j.apsb.2025.06.014","article-title":"Targeted inhibition of macrophage STING signaling alleviates inflammatory injury and ventricular remodeling in acute myocardial infarction","volume":"15","author":"Yao","year":"2025","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109026_bb0765","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Myocardial reperfusion injury","volume":"357","author":"Yellon","year":"2007","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109026_bb0770","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1080\/21655979.2021.1965812","article-title":"MicroRNA \u2212148 alleviates cardiac dysfunction, immune disorders and myocardial apoptosis in myocardial ischemia-reperfusion (MI\/R) injury by targeting pyruvate dehydrogenase kinase (PDK4)","volume":"12","author":"Yin","year":"2021","journal-title":"Bioengineered"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109026_bib837","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jacc.2021.07.018","article-title":"Innate lymphoid cells promote recovery of ventricular function after myocardial infarction","volume":"78","author":"Yu","year":"2021","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109026_bb0775","doi-asserted-by":"crossref","first-page":"223","DOI":"10.26599\/1671-5411.2023.03.004","article-title":"CD137 signaling aggravates myocardial ischemia-reperfusion injury by inhibiting mitophagy mediated NLRP3 inflammasome activation","volume":"20","author":"Zang","year":"2023","journal-title":"Journal of Geriatric Cardiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109026_bb0780","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.70043","article-title":"Ex vivo single-cell profiling of acute myocardial infarction patients reveals disproportionate CD66b+ cell secretion response","volume":"10","author":"Zeming","year":"2025","journal-title":"Bioengineering & Translational Medicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109026_bb0785","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00109-015-1288-9","article-title":"TIPE2 acts as a negative regulator linking NOD2 and inflammatory responses in myocardial ischemia\/reperfusion injury","volume":"93","author":"Zhang","year":"2015","journal-title":"Journal of Molecular Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109026_bb0790","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152681","article-title":"The fifth domain of Beta 2 glycoprotein I protects from natural IgM mediated cardiac Ischaemia reperfusion injury","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.109026_bb0795","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/cvr\/cvx130","article-title":"Insights into innate immune signalling in controlling cardiac remodelling","volume":"113","author":"Zhang","year":"2017","journal-title":"Cardiovascular Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109026_bb0800","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1007\/s10753-021-01467-2","article-title":"New insights and novel therapeutic potentials for macrophages in myocardial infarction","volume":"44","author":"Zhang","year":"2021","journal-title":"Inflammation"},{"issue":"94","key":"10.1016\/j.pharmthera.2026.109026_bb0805","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add1967","article-title":"Resident tissue macrophages: Key coordinators of tissue homeostasis beyond immunity","volume":"9","author":"Zhao","year":"2024","journal-title":"Science Immunology"},{"key":"10.1016\/j.pharmthera.2026.109026_bb0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103400","article-title":"LGR6 protects against myocardial ischemia-reperfusion injury via suppressing necroptosis","volume":"78","author":"Zhao","year":"2024","journal-title":"Redox Biology"},{"issue":"8a","key":"10.1016\/j.pharmthera.2026.109026_bb0815","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1111\/j.1582-4934.2009.00798.x","article-title":"Deficiency in TLR4 signal transduction ameliorates cardiac injury and cardiomyocyte contractile dysfunction during ischemia","volume":"13","author":"Zhao","year":"2009","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109026_bb0820","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.cell.2015.12.057","article-title":"NF-\u03baB restricts Inflammasome activation via elimination of damaged mitochondria","volume":"164","author":"Zhong","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109026_bb0825","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/tri.12197","article-title":"Long pentraxin PTX3 attenuates ischemia reperfusion injury in a cardiac transplantation model","volume":"27","author":"Zhu","year":"2014","journal-title":"Transplant International: Official Journal of the European Society for Organ Transplantation"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109026_bb0830","doi-asserted-by":"crossref","first-page":"H2805","DOI":"10.1152\/ajpheart.00299.2008","article-title":"Critical role of extracellular heat shock cognate protein 70 in the myocardial inflammatory response and cardiac dysfunction after global ischemia-reperfusion","volume":"294","author":"Zou","year":"2008","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109026_bb0835","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/cvr\/cvy304","article-title":"Innate immunity as a target for acute cardioprotection","volume":"115","author":"Zuurbier","year":"2019","journal-title":"Cardiovascular Research"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826000537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826000537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:10:43Z","timestamp":1776435043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725826000537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":167,"alternative-id":["S0163725826000537"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109026","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innate immune responses following myocardial ischemia and reperfusion: Evidence, mechanisms, and translational challenges","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109026"}}